Mavish S Chaudry1, Nicholas Carlson2,3, Gunnar H Gislason4,2,5, Anne-Lise Kamper6, Marianne Rix6, Vance G Fowler7, Christian Torp-Pedersen8, Niels E Bruun. 1. Department of Cardiology, Herlev-Gentofte Hospital University of Copenhagen, Copenhagen, Denmark; mavish89@hotmail.com. 2. The Danish Heart Foundation, Copenhagen, Denmark. 3. Department of Internal Medicine, Holbaek Hospital, Holbaek, Denmark. 4. Department of Cardiology, Herlev-Gentofte Hospital University of Copenhagen, Copenhagen, Denmark. 5. The National Institute of Public Health, University of Southern Denmark, Odense, Denmark. 6. Department of Nephrology, University Hospital Copenhagen Rigshospitalet, Copenhagen, Denmark. 7. Division of Infectious Diseases and International Health, Department of Medicine, Duke University School of Medicine, Durham, North Carolina; and. 8. Department of Cardiology and Clinical Epidemiology, Aalborg University Hospital and Department of Health Science and Technology, and.
Abstract
BACKGROUND AND OBJECTIVES: Endocarditis is a serious complication in patients treated with RRT. The study aimed to examine incidence and risk factors of endocarditis in patients with ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Danish National Registry on Regular Dialysis and Transplantation contains data on all Danish patients receiving renal replacement (hemodialysis, peritoneal dialysis, or kidney transplantation) for ESRD. Incidence of endocarditis was estimated for each RRT modality. Independent risk factors of endocarditis were identified in multivariable Cox regression models. RESULTS: From January 1st, 1996 to December 31st, 2012, 10,612 patients (mean age 63 years, 36% female) initiated RRT (7233 hemodialysis, 3056 peritoneal dialysis, 323 pre-emptive kidney transplantation). Endocarditis developed in 267 (2.5%); of these 31 (12%) underwent valve surgery. The overall incidence of endocarditis was 627 per 100,000 person-years in patients receiving RRT. Incidence was higher in patients receiving hemodialysis compared with those receiving peritoneal dialysis or kidney transplantation (1092 per 100,000 person-years, 212 per 100,000 person-years, and 85 per 100,000 person-years, respectively). Adjusted hazard ratios for endocarditis in patients receiving hemodialysis were 5.46 (95% confidence interval [95% CI], 3.28 to 9.10) and 0.41 (95% CI, 0.18 to 0.91) for kidney-transplanted recipients, respectively, as compared with patients in peritoneal dialysis. The incidence of endocarditis in hemodialysis recipients with central venous catheters was more than two-fold higher as compared with those with arteriovenous fistulas. Overall mortality, subsequent to endocarditis, was 22% in-hospital and 51% at 1 year. The first 6 months in RRT, aortic valve disease, and previous endocarditis were identified as significant risk factors of endocarditis. CONCLUSIONS: Patients receiving RRT have a high incidence of endocarditis, in particular during hemodialysis treatment using central venous catheters. The first 6 months in RRT, aortic valve disease, and previous endocarditis are significant risk factors for developing endocarditis.
BACKGROUND AND OBJECTIVES:Endocarditis is a serious complication in patients treated with RRT. The study aimed to examine incidence and risk factors of endocarditis in patients with ESRD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Danish National Registry on Regular Dialysis and Transplantation contains data on all Danish patients receiving renal replacement (hemodialysis, peritoneal dialysis, or kidney transplantation) for ESRD. Incidence of endocarditis was estimated for each RRT modality. Independent risk factors of endocarditis were identified in multivariable Cox regression models. RESULTS: From January 1st, 1996 to December 31st, 2012, 10,612 patients (mean age 63 years, 36% female) initiated RRT (7233 hemodialysis, 3056 peritoneal dialysis, 323 pre-emptive kidney transplantation). Endocarditis developed in 267 (2.5%); of these 31 (12%) underwent valve surgery. The overall incidence of endocarditis was 627 per 100,000 person-years in patients receiving RRT. Incidence was higher in patients receiving hemodialysis compared with those receiving peritoneal dialysis or kidney transplantation (1092 per 100,000 person-years, 212 per 100,000 person-years, and 85 per 100,000 person-years, respectively). Adjusted hazard ratios for endocarditis in patients receiving hemodialysis were 5.46 (95% confidence interval [95% CI], 3.28 to 9.10) and 0.41 (95% CI, 0.18 to 0.91) for kidney-transplanted recipients, respectively, as compared with patients in peritoneal dialysis. The incidence of endocarditis in hemodialysis recipients with central venous catheters was more than two-fold higher as compared with those with arteriovenous fistulas. Overall mortality, subsequent to endocarditis, was 22% in-hospital and 51% at 1 year. The first 6 months in RRT, aortic valve disease, and previous endocarditis were identified as significant risk factors of endocarditis. CONCLUSIONS:Patients receiving RRT have a high incidence of endocarditis, in particular during hemodialysis treatment using central venous catheters. The first 6 months in RRT, aortic valve disease, and previous endocarditis are significant risk factors for developing endocarditis.
Authors: Uday S Nori; Anup Manoharan; John I Thornby; Jerry Yee; Ravi Parasuraman; Venkataraman Ramanathan Journal: Nephrol Dial Transplant Date: 2006-04-27 Impact factor: 5.992
Authors: Sandra K Thygesen; Christian F Christiansen; Steffen Christensen; Timothy L Lash; Henrik T Sørensen Journal: BMC Med Res Methodol Date: 2011-05-28 Impact factor: 4.615
Authors: Mavish S Chaudry; Gunnar H Gislason; Anne-Lise Kamper; Marianne Rix; Anders Dahl; Lauge Østergaard; Emil L Fosbøl; Trine K Lauridsen; Louise B Oestergaard; Christian Hassager; Christian Torp-Pedersen; Niels E Bruun Journal: BMC Nephrol Date: 2018-09-03 Impact factor: 2.388
Authors: Saleh A Alghamdi; Abdulaziz M Alkhammash; Abdulrahman F Alotaibi; Saeed A Bugshan; Nawaf K Alshanbri; Mohammed Zahrani Journal: Cureus Date: 2021-06-28
Authors: Peter J Gallacher; David A McAllister; Nicholas L Mills; Nicholas L Cruden; Anoop S V Shah; Neeraj Dhaun Journal: J Am Heart Assoc Date: 2021-09-28 Impact factor: 5.501